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High-risk human papillomaviruses (HPVs) could be important risk factors for breast carcinogenesis and metastasis. Based on this
hypothesis, we recently studied the effect of E6/E7 onco-proteins of high-risk HPV type 16 in two non-invasive human breast cancer
cell lines, BT20 and MCF7; we reported that E6/E7 converts these cell lines to invasive cells. This is accompanied by an
overexpression of Id-1, which is an important regulator of breast metastasis. In this investigation, we examined the presence of high-
risk HPVs (16, 18, 31, 33 and 35) and the expression of their E6 onco-protein as well as their correlation with Id-1 gene expression,
using polymerase chain reaction (PCR) and tissue microarray (TMA) analysis, respectively, in a cohort of 113 Syrian breast cancer
patients. We found that high-risk HPV types 16, 18, 31, 33 and 35 are present in 8.84, 9.73, 7.07, 55.75 and 37.16% of our samples,
respectively, which represent invasive breast cancers. Overall, 69 (61.06%) of the 113 samples are HPV positive; among these
specimens 24 tissues (34.78%) are coinfected with more than one HPV type. Furthermore, we report that the expression of the E6
onco-protein of these high-risk HPVs is correlated with Id-1 overexpression in the majority of invasive breast cancer tissue samples.
Our data suggest that high-risk HPV infections are associated with human breast cancer progression in Syrian women.
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High-risk human papillomaviruses (HPVs) are important risk
factors for numerous human cancers including cervical, colorectal
and head and neck (HN); as roughly 96, 80 and 28% of these
cancers are positive for high-risk HPVs, respectively (Damin et al,
2007; Sturgis and Cinciripini, 2007; de Sanjose ´ et al, 2007). In
addition, the presence of high-risk HPVs serve as prognostic
factors in early-stage cervical, colorectal and HN cancers, and are
associated with vascular invasion, lymph node metastases and
tumour size (Begum et al, 2003; Graflund et al, 2004; Zuna et al,
2004; Umudum et al, 2005; Varnai et al, 2006). The E6 and E7
onco-proteins of high-risk HPVs, which are constitutively
expressed in these cancers, inactivate p53 and pRb tumour
suppressors, respectively (Vousden, 1995). E6 facilitates the
degradation of p53 through its association with an accessory
protein, E6-AP, a component of the ubiquitin proteolytic pathway
(Scheffner et al, 1993). Although, E7 proteins of high-risk HPVs
bind to Rb (Dyson et al, 1989), as well as to other pocket proteins,
such as p107 and p130 (Dyson et al, 1992), leading to cell cycle
deregulation. This results in genomic instability and has been
implicated in the progression of normal cells into cancer cells.
Several recent studies reported that approximately 50% of
human breast cancers are positive for high-risk HPVs, especially
types 16, 18 and 33 (Yu et al, 2000; Liu et al, 2001; de Villiers et al,
2005; Kan et al, 2005); controversially a few studies revealed that
HPVs could not be detected in breast cancer and normal tissues
(Gopalkrishna et al, 1996; Lindel et al, 2007). On the other hand,
studies that found HPV-positive samples revealed that certain
types of high-risk HPV infections are linked to specific geographic
locations. According to this observation, we recently reported that
HPV type 16 is the only type of high-risk HPV present in breast
cancer tissues of Canadian women (Yasmeen et al, 2007a).
The Id-1 gene (inhibitor of differentiation and DNA binding), a
member of the helix-loop-helix transcription factor family, has
multiple functions, including inhibition of differentiation, induc-
tion of proliferation and delaying replicative senescence (Fong
et al, 2004; Sikder et al, 2003). Moreover, Id-1 has been suggested
as a potential oncogene, because it is upregulated in many types of
human cancer such as breast, prostate and cervical (Lin et al, 2000;
Schindl et al, 2001; Ouyang et al, 2002). In breast cancer patients,
enhanced Id-1 expression is correlated with more aggressive
behaviour as well as much shorter overall survival (Schoppmann
et al, 2003; Jang et al, 2006). These studies suggest that Id-1 plays a
positive role in promoting the development and progression of
human breast cancer.
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sThis study aims to recognise the specific types of high-risk HPV
infections present in Syrian women and their association with
tumour aggressiveness and Id-1 overexpression.
MATERIALS AND METHODS
HPV detection and type specification
A total of 113 blocks from breast cancer patients with a median age
of 52 (range, 26–66) years were used in this study. Formalin-fixed
(buffered neutral aqueous 10% solution), paraffin-embedded
tumour materials were obtained from the Department of
Pathology, Faculty of Medicine, University of Aleppo. The use of
these specimens and data in research was approved by the Ethics
Committee of the Faculty of Medicine of Aleppo University. Five
mg of purified DNA (from each sample) was analysed for HPV by
multiplex PCR targets to the conserved L1 region of the viral
genome by use of PGMY09/11 L1 primer pools (Begum et al, 2003;
Yasmeen et al, 2007a,b). In parallel, we used specific primers for
E6 and E7 genes to detect HPV types 16, 18, 31, 33 and 35, whereas,
specific primers for the GAPDH gene were used as an internal
control (Table 1). PCR products were denatured in 0.13N NaOH
and hybridised to an immobilised HPV probe array using an
extended reverse line-blot assay for HPV genotyping (Roche
Molecular Systems Inc., Alameda, CA, USA) of five HPV types
classified as high-risk HPVs (types 16, 18, 31, 33 and 35) as
described by Begum et al (2003).
Tissue microarray
The tissue microarray (TMA) construction was performed as
described by Kuefer et al (2004). Briefly, tissue cylinders with a
diameter of 0.6mm were punched from representative tumour
areas of a ‘donor’ tissue block using a semiautomatic robotic
precision instrument. Two sections of the TMA blocks were
transferred to an adhesive coated slide system (Instrumedics Inc.,
Hackensack, NJ, USA). Slides of the finished blocks were used for
immunohistochemistry analysis.
Immunohistochemistry
Immunohistochemical procedures examining the expression of
Id-1 and E6 were carried out using standard procedures as
previously described (Al Moustafa et al, 2004). Primary specific
antibodies were obtained from Santa Cruz Biotechnology and
Calbiochem. Briefly, TMA sections were deparaffinised, rehydrated
and endogenous peroxidase activity within the rehydrated tissue
was blocked with a solution of 3% hydrogen peroxide in methanol
for 10min at room temperature. Antigen retrieval was carried out
by boiling in 10mM sodium citrate solution (pH 6.0) for 10min.
The TMA slides were cooled and equilibrated in Optimaxt wash
buffer then incubated overnight (15h) at 41C with primary
antibodies for Id-1 (rabbit polyclonal; sc-488; Santa Cruz
Biotechnology, Santa Cruz, CA, USA) and E6 (mouse monoclonal;
clone C1P5; Calbiochem, San Diego, CA, USA). In all cases, the
diluent was 0.6% BSA in Optimax wash buffer. Sections were then
washed (41min), and the appropriate secondary HRP-conju-
gated antibody was applied for 1h at room temperature
(Calbiochem, Canada). The slides were counterstained with
haematoxylin and mounted.
RESULTS
To determine the role of high-risk HPV infections in human breast
cancer in Middle Eastern women, we investigated the presence of
high-risk HPV types 16, 18, 31, 33 and 35 in a cohort of 113 breast
cancer samples from Syrian women by PCR analysis using specific
primers for their E6 and/or E7 genes (Table 1). Our study revealed
that 69 (61.06%) of the 113 samples are HPV positive and 24
(34.78%) of these specimens are coinfected with more than one
HPV type (Table 2). We found that HPV types 16, 18 and 31 are
present in only 10, 11 and 8 cancer tissues, respectively (Table 3).
In contrast, 63 and 42 cancer tissues were positive for HPV types
33 and 35, respectively (Table 3).
To assess the association between the presence of HPV types 16,
18, 31, 33 and 35 with tumour aggressiveness and Id-1 expression
in breast cancer in Syrian women, we examined the expression of
the E6 onco-protein of high-risk HPVs along with Id-1 expression
Table 1 The specific primer sets for E6 and/or E7 genes of high-risk
HPVs used for PCR amplification
HPV types Region Primers
16 E6 5’-ATGCACCAAAAGAGAACTGCA-3’
5’-TTACAGCTGGGTTTCTCTACG-3’
16 E7 5’-ATGCATGGAGATACACCTACATTGCAT-3’
5’-GTTTCTGAGAACAGATGGGGCACAC-3’
18 E6 5’-GCTTTGAGGATCCAACACGG-3’
5’-TGCAGCACGAATGGCACTGG-3’
31 E7 5’-GGGCTCATTTGGAATCGTGTG-3’
5’-AACCATTGCATCCCGTCCCC-3’
33 E6 5’-TGTAACCGAAAGCGGTTCAA-3’
5’-TAACGTTGGCTTGTGTCCTCTC-3’
33 E7 5’-TGAGGATGAAGGCTTGGACC-3’
5’-TGACACATAAACGAACTGTG-3’
35 E6 5’-GGTCGTACCGAAAACGGTTG-3’
5’- GTTGCCTCGGGTTCCAAATC-3’
35 E7 5’-CTATTGACGGTCCAGCT-3’
5’-TACACACAGACGTAGTGTCG-3’
Primers specific for the GAPDH gene, 5’-GAAGGC-CATGCCAGTGAGCT-3’ and
5’-CCGGGAAACTGTGGCGTGAT-3’, were used as an internal control.
Table 3 Presence of HPV types 16, 18, 31, 33 and 35 in invasive and
in-situ breast carcinomas
HPV types
Breast cancer No of cases 16 18 31 33 35
Invasive 87 9/87 11/87 8/87 58/87 39/87
In situ 26 1/26 0/26 0/26 5/26 3/26
The presence of high-risk HPVs is more frequent in invasive breast cancer in
comparison to in situ breast cancer tissues (Po0.0001 and 0.024). Furthermore, it is
clear that HPV type 33 and 35 are more common in breast cancer in Syrian women.
Table 2 High-risk HPV (16, 18, 31, 33 and 35) detection in breast
carcinomas by PCR
Tested cases Positive Percentage
Breast cancer tissues 113 69 61.06
The incidences of these viruses were found in 69 samples out of 113 examined using
specific primers for E6 and/or E7 of each HPV type (Po0.01). We noted that
24 samples of the 69 are infected with more than one HPV type (Po0.01).
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sin all our breast tissue samples by immunohistochemistry using
tissue microarray methodology. We found that E6 expression is
correlated with Id-1 overexpression in 94.25% of invasive breast
cancer samples as opposed to 30.76% of in situ cancer tissues
(Table 4 and Figure 1); whereas we presume that these in situ
breast carcinomas, which are HPV-positive, will ultimately
progress into invasive carcinomas under the effect of these HPVs,
as they are already intermediate to high nuclear grade. Moreover,
to confirm the association between E6/E7 of HPV types 16, 18, 31,
33 and 35 and Id-1, we investigated the presence of E6 and/or E7 of
these viruses by PCR using specific primers for E6/E7 genes
(Table 1). By means of this analysis, we were able to prove that E6/
E7 of HPV types 16, 18, 31, 33 and 35 are present in the majority of
invasive breast cancer tissues; and their presence is associated with
Id-1 overexpression (Table 4).
DISCUSSION
This is, to the best of our knowledge, the first study on the
presence of high-risk HPVs and their relation with tumour
aggressiveness in breast cancer in Syrian women. Earlier studies
on breast cancer have reported that HPV types 11, 16 and 18 are
the most frequent in women living in the United States and Brazil
(Liu et al, 2001; Damin et al, 2004); and HPV type 18 is present in
the majority of Australian women (Kan et al, 2005). In parallel,
HPV type 33 is the most frequent virus in Asian women (Yu et al,
1999, 2000). HPV type 16 has been identified in Italian and
Norwegian women who had previous cervical neoplasias (Hennig
et al, 1999). Moreover, we recently reported that HPV type 16 is the
only type present in Canadian women. However, studies on the
presence of high-risk HPV in the Middle East reveal that HPV
types 18, 33 and 35 are present in breast cancer and normal
mammary tissues in Turkish women (Gumus et al, 2006). On the
other hand, the presence of HPVs in human breast cancer tissues
varies from 12.9 to 86% (de Villiers et al, 2005; Tsai et al, 2005). In
this study, we report that HPVs are present in 61.06% of breast
cancer in Syrian women; moreover, HPV types 33 and 35 are the
predominant viruses of the high-risk HPV family in these breast
cancer tissues. Therefore, our data confirm that specific types of
high-risk HPV infection, in breast tissues, are related to specific
geographic locations.
Regarding the association between high-risk HPV and tumour
aggressiveness, recent studies, including ours, have reported that
the presence of HPV type 16, in human breast cancer, is correlated
with invasive carcinomas (Kroupis et al, 2006; Yasmeen et al,
2007a). Moreover, we demonstrated that E6/E7 onco-proteins of
HPV type 16 convert non-invasive breast cancer cells to an
invasive phenotype (Yasmeen et al, 2007a); this is accompanied by
an overexpression of Id-1, which regulates cell invasion and
metastasis of human breast cancer cells (Desprez et al, 1998; Fong
et al, 2003). In this study, we investigated the relation between
high-risk HPVs and Id-1 expression in breast cancer tissues from
Syrian women. We report, for the first time, that the presence of
E6/E7 onco-proteins of HPV types 16, 18, 31, 33 and 35 are
associated with Id-1 overexpression. Recently, Minn et al (2005)
identified a subset of genes that mediate lung metastasis of human
breast cancer; Id-1 was revealed as one of these important genes.
We recently found that human breast cancer cells expressing E6/E7
of HPV type 16 display a major lung metastatic activity when
compared with their wild type cells in vivo. Separately, we reported
that the presence of E6/E7 of HPV type 16 is correlated with Id-1
overexpression in human invasive and metastatic breast cancer
tissues in Canadian women. Moreover, we revealed that E6/E7 of
HPV type 16 affects Id-1 deregulation through the activation of its
promoter (Yasmeen et al, 2007a). Therefore, the present study
clearly suggests that Id-1 is the downstream target of E6/E7 of HPV
types 18, 31, 33 and 35 in human breast cancer progression.
In conclusion, we demonstrate that high-risk HPV types 16, 18,
31, 33 and 35 are present in human breast cancer in Syrian women.
In addition, HPV types 33 and 35 are the most dominant types of
HPV infection found in Middle Eastern women, based on the
combination of this study and a study by Gumus et al (2006). In
parallel, we report that Id-1 is an important target for E6/E7 onco-
proteins of HPV type 16, 18, 31, 33 and 35 in breast cancer cells.
Our findings provide a new basis for understanding the mecha-
nisms of high-risk HPV infections and their relation to human
breast cancers. However, we firmly believe that further studies are
required to elucidate the role and pathogenesis of high-risk HPV in
human breast cancer, especially because HPV vaccines for only
two high-risk HPV types are available at present. Therefore, it is of
great interest to gain a better understanding of the association
between HPV infections and breast cancer progression.
Table 4 Correlation between the expression of the E6 onco-protein of
high-risk HPVs and Id-1 in breast cancer tissues using tissue microarray
analysis
Breast cancer No of cases E6 of HPV Id-1
Invasive 87 82/87 84/87
In situ 26 11/26 8/26
The expression of the E6 onco-protein is associated with Id-1 overexpression in the
majority of invasive breast cancer tissues (Po0.0001). In contrast, this coexpression is
limited to 8 cases out of 26 in in situ breast cancer (Po0.0001). Furthermore, the
expression levels of Id-1 in these tissues vary from weak to moderate.
Id-1 E6
Figure 1 Association between the presence of HPV type 33 and Id-1 overexpression in human invasive breast cancer in a sample patient. We noted that
E6 expression of HPV type 33 is correlated with Id-1 overexpression in invasive breast cancer using tissue microarray analysis. Magnification is 200. The
presence of HPV type 33 was confirmed by PCR using specific primers for the E6 gene of this virus.
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